JPWO2020004014A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020004014A5
JPWO2020004014A5 JP2020527369A JP2020527369A JPWO2020004014A5 JP WO2020004014 A5 JPWO2020004014 A5 JP WO2020004014A5 JP 2020527369 A JP2020527369 A JP 2020527369A JP 2020527369 A JP2020527369 A JP 2020527369A JP WO2020004014 A5 JPWO2020004014 A5 JP WO2020004014A5
Authority
JP
Japan
Prior art keywords
ascorbic acid
glucoside
ergothioneine
muscle differentiation
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020527369A
Other languages
English (en)
Japanese (ja)
Other versions
JP7759724B2 (ja
JPWO2020004014A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/023114 external-priority patent/WO2020004014A1/ja
Publication of JPWO2020004014A1 publication Critical patent/JPWO2020004014A1/ja
Publication of JPWO2020004014A5 publication Critical patent/JPWO2020004014A5/ja
Priority to JP2023203550A priority Critical patent/JP2024026241A/ja
Priority to JP2025114256A priority patent/JP2025148417A/ja
Application granted granted Critical
Publication of JP7759724B2 publication Critical patent/JP7759724B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020527369A 2018-06-29 2019-06-11 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用 Active JP7759724B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023203550A JP2024026241A (ja) 2018-06-29 2023-12-01 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP2025114256A JP2025148417A (ja) 2018-06-29 2025-07-07 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018124613 2018-06-29
JP2018124613 2018-06-29
PCT/JP2019/023114 WO2020004014A1 (ja) 2018-06-29 2019-06-11 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023203550A Division JP2024026241A (ja) 2018-06-29 2023-12-01 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Publications (3)

Publication Number Publication Date
JPWO2020004014A1 JPWO2020004014A1 (ja) 2021-07-15
JPWO2020004014A5 true JPWO2020004014A5 (enExample) 2022-06-17
JP7759724B2 JP7759724B2 (ja) 2025-10-24

Family

ID=68986429

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020527369A Active JP7759724B2 (ja) 2018-06-29 2019-06-11 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP2023203550A Pending JP2024026241A (ja) 2018-06-29 2023-12-01 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP2025114256A Pending JP2025148417A (ja) 2018-06-29 2025-07-07 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023203550A Pending JP2024026241A (ja) 2018-06-29 2023-12-01 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP2025114256A Pending JP2025148417A (ja) 2018-06-29 2025-07-07 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Country Status (6)

Country Link
US (1) US12454678B2 (enExample)
EP (1) EP3816278A4 (enExample)
JP (3) JP7759724B2 (enExample)
CN (1) CN112352046A (enExample)
TW (1) TWI815907B (enExample)
WO (1) WO2020004014A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022230487A1 (enExample) * 2021-04-26 2022-11-03
WO2022242711A1 (en) * 2021-05-20 2022-11-24 Nanjing Nutrabuilding Bio-Tech Co., Ltd. Methods for ameliorating and preventing age‐related muscle degeneration
JP7569818B2 (ja) * 2022-03-11 2024-10-18 キッコーマン株式会社 エルゴチオネインを光に対し安定化させた液体組成物
JPWO2024172003A1 (enExample) * 2023-02-16 2024-08-22
DE102023131771B3 (de) 2023-09-15 2025-02-06 Esspen Gmbh Verfahren und Vorrichtung zur Verarbeitung medizintechnischer Bilddaten im Zusammenhang mit einer Trepanation
WO2026148341A1 (en) * 2025-01-06 2026-07-09 Mironova Labs, Inc ʟ-ERGOTHIONEINE COCRYSTAL AND DERIVATIVES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099277A1 (en) 2002-05-20 2003-12-04 Oxis International, Inc. Method of reducing incidence diabetic embryopathy with l-ergothioneine
US20100227307A1 (en) 2007-04-12 2010-09-09 Hausman Marvin S Ergothioneine and/or its derivatives as a cell preservative
FR2924334B1 (fr) 2007-11-30 2016-03-25 Lvmh Rech Composition cosmetique comprenant l'acide 2-glucoside ascorbique et l'ergothioneine.
US20110262965A1 (en) * 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
US20120141611A1 (en) * 2010-12-05 2012-06-07 Oxis International Inc. Methods and compositions using ergothioneine to treat a variety of health related factors
CA2877861A1 (en) * 2012-06-26 2014-01-03 Entia Biosciences, Inc. A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
TWI549696B (zh) 2014-09-05 2016-09-21 中國醫藥大學 麥角硫因應用於活化細胞之Ｎｒｆ２訊息途徑之用途

Similar Documents

Publication Publication Date Title
Warinner et al. Ancient human microbiomes
Freire et al. Impact of multi-functional fermented goat milk beverage on gut microbiota in a dynamic colon model
WO2016057951A3 (en) Crispr oligonucleotides and gene editing
EP1937091A4 (en) GRAPE EXTRACT, GRAPE EXTRACT FOOD ADDITIVE, AND METHOD THEREFOR
MY177340A (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
JP2014158488A5 (enExample)
WO2012060579A3 (ko) 항균용 유산균 사균체 및 이의 제조방법
EP4559902A3 (en) Kdm1a inhibitors for the treatment of disease
WO2018020323A3 (en) Materials and methods for treatment of fatty acid disorders
EP1941892A3 (en) Anti-allergy lactic acid bacteria
JP2016065039A5 (enExample)
WO2016190683A8 (ko) 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
PH12015500628B1 (en) Method for preparing natural kokumi flavor
HK1200062A1 (en) Dairy based compositions with low lps
HK1208993A1 (en) Obesity animal model and methods for making and using thereof
MY175057A (en) Method for preparing natural neutral flavor
PH12015500631A1 (en) Method for preparing natural beef flavor
PH12016500025A1 (en) Methods for promoting neuronal development and/or health
WO2012124978A3 (ko) 3차원 세포배양으로 수득한 조정 배지를 유효성분으로 포함하는 허혈성 질환 치료용 약학적 조성물
CN106471121A8 (zh) 减少功能蛋白的水平基因转移
JP2017190308A5 (enExample)
WO2011037712A3 (en) Nutritional compositions including theanine and exogenous nucleotides
WO2014092564A8 (en) Nutritional composition with non digestible oligosaccharides
CN104082790A (zh) 一种果香糟鱼的制备工艺
RU2006137846A (ru) Способ консервирования зеленых кормов